FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On March 12, 2004
Table of Contents
Docket # Title
1992V-0286 Variance Request for Mobilazer ML-10A Light Show
1995N-0304 Ephedrine Alkaloids: Reports of Adverse Events; Availability
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
2003P-0238 ANDA Suitability Petition for Clarithromycin Extended-Release Tablets
2004P-0125 Sertraline hydrochloride tablets, 150 mg and 200 mg are suitable for submission in an ANDA
2004P-0126 Classification of CellSearch Epithelial Cell Kit/Cell Spotter Analyzer
1992V-0286 Variance Request for Mobilazer ML-10A Light Show
ACK 3 HFA-305 to Dreamspell Vol #: 1
VAR 3 Dreamspell Vol #: 1
1995N-0304 Ephedrine Alkaloids: Reports of Adverse Events; Availability
ACK 3 HFA-305 to Kleinfeld, Kaplan and Becker Vol #: 374
PRC 1 Chinese Herbal Products Committee of the American Herbal Products Association Vol #: 374
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 13211 Enzymatic Therapy Natural Medicines Vol #: 107
LET 13212 Source Naturals Vol #: 108
LET 13213 Enzymatic Therapy Natural Medicines Vol #: 108
LET 13214 Enzymatic Therapy Natural Medicines Vol #: 108
LET 13215 Highland Laboratories Vol #: 108
LET 13216 Highland Laboratories Vol #: 108
LET 13217 Body Wise International, Inc. Vol #: 108
LET 13218 Body Wise International, Inc. Vol #: 108
LET 13219 Body Wise International, Inc. Vol #: 108
LET 13220 Body Wise International, Inc. Vol #: 108
LET 13221 Enzymatic Therapy Natural medicines Vol #: 108
LET 13222 Enzymatic Therapy Natural Medicines Vol #: 108
LET 13223 Enzymatic Therapy Natural Medicines Vol #: 108
LET 13224 Master Herbs (USA) Inc. Vol #: 108
LET 13225 Enzymatic Therapy Natural Medicines Vol #: 108
LET 13226 Enzymatic Therapy Natural Medicines Vol #: 108
LET 13227 Numark Laboratories, Inc. Vol #: 108
LET 13228 NOW Foods Vol #: 108
LET 13229 Banner Pharmacaps Inc. Vol #: 108
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
EMC 4221 A. Wamsly Vol #: 168
EMC 4222 L. Gluck Vol #: 168
EMC 4223 J.E. Crowell Vol #: 168
EMC 4224 K. Manger Vol #: 168
EMC 4225 E. Morin Vol #: 168
EMC 4226 M. S. Fussner Vol #: 168
EMC 4227 J. Plummer Vol #: 168
EMC 4228 B. Pampalone Vol #: 168
EMC 4229 D. Suggs Vol #: 168
EMC 4230 N. Pfahler Vol #: 168
EMC 4231 A. Rocchio Vol #: 168
EMC 4232 L. Bedri Vol #: 168
EMC 4233 C. Elliott Vol #: 168
EMC 4234 Dr. J. Bein Vol #: 168
EMC 4235 J. Cogan Vol #: 168
EMC 4236 G. Bertani Vol #: 168
EMC 4237 Bonnie D. Vol #: 168
EMC 4238 R. Badger Vol #: 168
EMC 4239 A. C. Chisolm Vol #: 168
EMC 4240 E. Franklin Vol #: 168
EMC 4241 J. Mann Vol #: 168
EMC 4242 N. Mckay Vol #: 168
EMC 4243 M. Blough Vol #: 168
EMC 4244 A. Loeblich Vol #: 168
EMC 4245 A. Lombardi Vol #: 168
EMC 4246 A. Trader Vol #: 168
EMC 4247 C. Kowalski Vol #: 168
EMC 4248 A. Cook Vol #: 168
EMC 4249 P. Shillam Vol #: 168
EMC 4250 G. Hamilton Vol #: 168
EMC 4251 F. Nussbaum Vol #: 168
EMC 4252 C. E. Campbell Vol #: 168
EMC 4253 L. Carroll Vol #: 168
EMC 4254 C. Werblun Vol #: 168
EMC 4255 L. Casini Vol #: 168
EMC 4256 C. Hasenick Vol #: 168
EMC 4257 A. Wilson Vol #: 168
EMC 4258 A. MTZ Vol #: 168
EMC 4259 W. L. Rossiter Vol #: 168
EMC 4260 S. Spencer Vol #: 168
EMC 4261 D. Schiel Vol #: 168
EMC 4262 S. Dieterle Vol #: 168
EMC 4263 E. Linson Vol #: 168
EMC 4264 G. German Vol #: 168
EMC 4265 E. Memel Vol #: 168
EMC 4266 C. Gallegos Vol #: 168
EMC 4267 P. Wilkins Vol #: 168
EMC 4268 Roxanne T. Vol #: 168
EMC 4269 G. Metz Vol #: 168
EMC 4270 D. Brown Vol #: 168
EMC 4271 E. Stein Vol #: 168
EMC 4272 J. Andrews Vol #: 168
EMC 4273 L. Florin Vol #: 168
EMC 4274 D. Hunter Vol #: 168
EMC 4275 M. L. Gradison Vol #: 168
EMC 4276 R. Poteat Vol #: 168
EMC 4277 J. E. Lobdell Vol #: 168
EMC 4278 G. H. B. Drayer Vol #: 168
EMC 4279 A. J Lipper Vol #: 168
EMC 4280 J. Michaels Vol #: 168
EMC 4281 X. Rekdal Vol #: 168
EMC 4282 D. Mims Vol #: 168
EMC 4283 F. Zajkowski Jr. Vol #: 167
EMC 4284 N. Laurenson Vol #: 167
EMC 4285 R. Fullerton Vol #: 168
EMC 4286 C. Farmer Vol #: 168
EMC 4287 D. Ewell Vol #: 168
EMC 4288 R. M. Loeser Vol #: 168
EMC 4289 V. J. Talbot Vol #: 168
EMC 4290 M. McEachern Vol #: 168
EMC 4291 S. Smith Vol #: 168
EMC 4292 G. Orcholski Vol #: 168
EMC 4293 K. Miller Vol #: 168
EMC 4294 E. Decicco Vol #: 168
EMC 4295 J. OConnor Vol #: 168
EMC 4296 P. Pine Vol #: 168
EMC 4297 J. Killian Vol #: 163
EMC 4298 B. & J. Tache Vol #: 168
EMC 4299 A. Nopola Vol #: 168
EMC 4300 S. D. Rain Vol #: 168
EMC 4301 C. Swan Vol #: 168
EMC 4302 T. Litvin Vol #: 168
EMC 4303 K. Watrous Vol #: 168
2003P-0238 ANDA Suitability Petition for Clarithromycin Extended-Release Tablets
AMD 1 The Weinberg Group Vol #: 1
2004P-0125 Sertraline hydrochloride tablets, 150 mg and 200 mg are suitable for submission in an ANDA
ACK 1 HFA-305 to Lachman Consultant Services, Inc. Vol #: 1
CP 1 Lachman Consultant Services, Inc. Vol #: 1
2004P-0126 Classification of CellSearch Epithelial Cell Kit/Cell Spotter Analyzer
CP 1 Veridex, LLC Vol #: 1
PAV 1 HFZ-440 to Veridex, LLC Vol #: 1

Page created on March 13, 2004 kk
Page udpated on March 22, 2004 jb

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management